PATENT CLAIM ANALYSIS

Application Number: 16149913
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["560", "124000"]

Abstract:
A method of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO in an individual by providing a composition comprising a compound set forth in Formula (I):

Claim (Index 9):
A method of improving a condition associated with the conversion of choline to trimethylamine (TMA) in an individual comprising administering to the individual a compound set forth in Formula (I): wherein: Y + =N + ; n is 1, 2 or 3; R 1  is selected from m is 0, 1 or 2; W is CH 2  or O; R 2 , R 3  are independently selected from C 1 -C 4  alkyl, or bound together to form part of a ring system; R 4  is H, C 1 -C 4  alkyl, or is absent when the compound exists as a carboxylate ion; X \u2212  is a pharmaceutically acceptable anion; and including any acceptable salts and solvates thereof;\n wherein the compound is administered in an amount effective to treat or prevent the disease or condition associated with choline-related trimethylamine (TMA) in the individual.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 97.0
- Lexical Diversity: 1.17241
- Patent Class: 560.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15366940', '14866398', '15605437', '13915299', '13363661']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.707103029453586
- 35 USC 102 Novelty (BERT): 0.5640149880623652
- Combined Prediction Score: 0.6927942253144639
- Mean Citation Score: 245.85887
- Max Citation Score: 376.33347
- Similarity Product: 262.05013586634453

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test